Core Laboratories (CLB) to Release Quarterly Earnings on Wednesday

Core Laboratories (NYSE:CLB) is scheduled to be issuing its quarterly earnings data after the market closes on Wednesday, January 31st. Analysts expect the company to announce earnings of $0.58 per share for the quarter.

Core Laboratories (CLB) opened at $120.30 on Wednesday. The stock has a market cap of $5,310.00, a price-to-earnings ratio of 69.54 and a beta of 1.56. Core Laboratories has a 1 year low of $86.55 and a 1 year high of $124.99. The company has a current ratio of 2.18, a quick ratio of 1.81 and a debt-to-equity ratio of 1.53.

The firm also recently announced a quarterly dividend, which will be paid on Friday, February 16th. Investors of record on Friday, January 26th will be given a dividend of $0.55 per share. The ex-dividend date is Thursday, January 25th. This represents a $2.20 dividend on an annualized basis and a yield of 1.83%. Core Laboratories’s dividend payout ratio is presently 127.17%.

CLB has been the subject of a number of research reports. Scotiabank set a $136.00 target price on shares of Core Laboratories and gave the company a “hold” rating in a research report on Wednesday, October 25th. Zacks Investment Research downgraded shares of Core Laboratories from a “hold” rating to a “sell” rating in a research report on Tuesday, September 26th. Loop Capital set a $115.00 target price on shares of Core Laboratories and gave the company a “buy” rating in a research report on Thursday, December 7th. Piper Jaffray Companies set a $97.00 target price on shares of Core Laboratories and gave the company a “hold” rating in a research report on Monday, October 23rd. Finally, ABN Amro downgraded shares of Core Laboratories from a “buy” rating to a “hold” rating in a research report on Tuesday, January 9th. Three investment analysts have rated the stock with a sell rating, eight have given a hold rating and four have issued a buy rating to the stock. The company presently has a consensus rating of “Hold” and an average target price of $110.20.

An institutional investor recently raised its position in Core Laboratories stock. The Manufacturers Life Insurance Company grew its position in Core Laboratories (NYSE:CLB) by 63.7% in the second quarter, according to the company in its most recent disclosure with the SEC. The firm owned 1,128 shares of the oil and gas company’s stock after acquiring an additional 439 shares during the period. The Manufacturers Life Insurance Company ‘s holdings in Core Laboratories were worth $114,000 at the end of the most recent quarter.

TRADEMARK VIOLATION NOTICE: This news story was posted by American Banking News and is owned by of American Banking News. If you are accessing this news story on another website, it was stolen and republished in violation of US and international trademark & copyright legislation. The legal version of this news story can be viewed at https://www.americanbankingnews.com/2018/01/24/core-laboratories-clb-to-release-quarterly-earnings-on-wednesday.html.

Core Laboratories Company Profile

Core Laboratories N.V. provides reservoir description, production enhancement and reservoir management services to the oil and gas industry. The Company operates through three segments: Reservoir Description, Production Enhancement and Reservoir Management. The Reservoir Description segment encompasses the characterization of petroleum reservoir rock, fluid and gas samples.

Earnings History for Core Laboratories (NYSE:CLB)

Receive News & Ratings for Core Laboratories Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Core Laboratories and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply